Atherosclerosis Imaging: A Biological and Clinical Perspective

Novel Techniques for Imaging the Heart: Cardiac MR and CT

Volumn , Issue , 2009, Pages 259-277

  Libby, Peter ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Atherosclerotic plague burden and arterial stenosis versus clinical events; Cardiovascular imaging in investigation and therapeutic development and evaluation; Clinician's perspective on integration of atherosclerosis imaging into practice; Endothelial activation; Macrophage accumulation and activation; Role of atherosclerosis imaging in primary prevention; Toward functional or molecular imaging of athersclerotic plagues; Use of imaging modalities in secondary prevention

Indexed keywords

EID: 84889769763     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444300598.ch17     Document Type: Chapter

References (67)

1. Tsimikas, S., et al. (2005) Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N Engl J Med 353(1): 46-57.
2. Libby, P., Ridker, P.M. (2006) Inflammation and atherothrombosis: from population biology and bench research to clinical practice. J Am Coll Cardiol 48: A33-46.
3. Hansson, G.K., Libby, P. (2006) The immune response in atherosclerosis: a doubleedged sword. Nat Rev Immunol 6(7): 508-519.
4. Corti, R., Fuster, V., Badimon, J.J. (2003) Pathogenetic concepts of acute coronary syndromes. J Am Coll Cardiol 41(4 Suppl S): 7S-14S.
5. Libby, P., Theroux, P. (2005) Pathophysiology of coronary artery disease. Circulation 111: 3481-3488.
6. Smith, S., Jr., (1996) Risk-reduction therapy: the challenge to change. Circulation 93(12): 2205-2211.
7. Bruschke, A.V., et al. (1989) The dynamics of progression of coronary atherosclerosis studied in 168 medically treated patients who underwent coronary arteriography three times. Am Heart J 117(2): 296-305.
8. Yokoya, K., et al. (1999) Process of progression of coronary artery lesions from mild or moderate stenosis to moderate or severe stenosis: a study based on four serial coronary arteriograms per year. Circulation 100(9): 903-909.
9. Hackett, D., Davies, G., Maseri, A. (1988) Pre-existing coronary stenoses in patients with first myocardial infarction are not necessarily severe. Eur Heart J 9(12): 1317-1323.
10. Loree, H.M., et al. (1992) Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels. Circ Res 71(4): 850-858.
11. Virmani, R., et al. (2006) Pathology of the vulnerable plaque. J Am Coll Cardiol 47(8 Suppl): C13-18.
12. Loree, H.M., et al. (1994) Static circumferential tangentialmodulusofhumanatherosclerotic tissue. J Biomech 27(2): 195-204.
13. Amento, E.P., et al. (1991) Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 11: 1223-1230.
14. Rekhter, M., et al. (1993) Type I collagen gene expression in human atherosclerosis. Localization to specific plaque regions. Am J Pathol 143: 1634-1648.
15. Henney, A.M., et al. (1991) Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci USA 88(18): 8154-8158.
16. Galis, Z., et al. (1994) Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94: 2493-2503.
17. Sukhova, G.K., et al. (1999) Evidence for increased collagenolysis by interstitial collagenases-1 and-3 in vulnerable human atheromatous plaques. Circulation 99(19): 2503-2509.
18. Sukhova, G.K., et al. (1998) Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 102(3): 576-583.
19. Herman, M.P., et al. (2001) Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma: a novel collagenolytic pathway suggested by transcriptional profiling. Circulation 104(16): 1899-1904.
20. Dollery, C.M., Libby, P. (2006) Atherosclerosis and proteinase activation. Cardiovasc Res 69(3): 625-635.
21. Nikkari, S.T., et al. (1995) Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation 92(6): 1393-1398.
22. Liu, J., et al. (2004) Lysosomal cysteine proteases in atherosclerosis. Arterioscler Thromb Vasc Biol 24(8): 1359-1366.
23. Fukumoto, Y., et al. (2004) Genetically determined resistance to collagenase action augments interstitial collagen accumulation in atherosclerotic plaques. Circulation 110(14): 1953-1959.
24. Deguchi, J.O., et al. (2005) Matrix metalloproteinase-13/collagenase-3 deletion promotes collagen accumulation and organization in mouse atherosclerotic plaques. Circulation 112(17): 2708-2715.
25. Mach, F., et al. (1997) Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation 96: 396-399.
26. Clarkson, T.B., et al. (1994) Remodeling of coronary arteries in human and nonhuman primates. JAMA 271(4): 289-294.
27. Glagov, S., et al. (1987) Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 316: 371-375.
28. Schoenhagen, P., et al. (2000) Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: an intravascular ultrasound study. Circulation 101(6): 598-603.
29. Schwartz, S.M. (1999) The intima: a new soil. Circ Res 85(10): 877-879.
30. Taylor, A.J. (2002) Atherosclerosis imaging to detect and monitor cardiovascular risk. Am J Cardiol 90(10C): 8L-11L.
31. Greenland, P., et al. (2007) ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA writing committee to update the 2000 expert consensus document on electron beam computed tomography). Circulation 115(3): 402-426.
32. Kronmal, R.A., et al. (2007) Risk factors for the progression of coronary artery calcification in asymptomatic subjects: results from the Multi-ethnic Study of Atherosclerosis (MESA). Circulation 115(21): 2722-2730.
33. Cordeiro, M.A., Lima, J.A. (2006) Atherosclerotic plaque characterization by multidetector row computed tomography angiography. J Am Coll Cardiol 47(8 Suppl): C40-47.
34. Fayad, Z.A., et al. (2002) Computed tomography and magnetic resonance imaging for noninvasive coronary angiography and plaque imaging: current and potential future concepts. Circulation 106(15): 2026-2034.
35. Greenland, P., et al. (2004) Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 291(2): 210-215.
36. Budoff, M.J., et al. (2007) Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol 49(18): 1860-1870.
37. Beckman, J.A., et al. (2001) Relationship of clinical presentation and calcification of culprit coronary artery stenoses. Arterioscler Thromb Vasc Biol 21(10): 1618-1622.
38. Loree, H.M., et al. (1994) Static circumferential tangentialmodulusofhumanatherosclerotic tissue. J Biomech 27(2): 195-204.
39. Vengrenyuk, Y., et al. (2006) A hypothesis for vulnerable plaque rupture due to stressinduced debonding around cellular microcalcifications in thin fibrous caps. Proc Natl Acad Sci USA 103(40): 14678-14683.
40. Jaffer, F.A., Libby, P.,Weissleder, R. (2007) Molecular imaging of cardiovascular disease. Circulation 116(9): 1052-1061.
41. Gimbrone, M.A., Jr., et al. (2000) Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann NY Acad Sci 902: 230-239; disc. 239-240.
42. Libby, P., Aikawa, M., Jain, M.K. (2006) Vascular endothelium and atherosclerosis. Handb Exp Pharmacol 176(Pt 2): 285-306.
43. Dai, G., et al. (2007) Biomechanical forces in atherosclerosis-resistant vascular regions regulate endothelial redox balance via phosphoinositol 3-kinase/Akt-dependent activation of Nrf2. Circ Res 101(7): 723-733.
44. Cybulsky, M.I., et al. (2001) A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 107(10): 1255-1262.
45. O'Brien, K., et al. (1993) Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques: implications for themodeof progression of advanced coronary atherosclerosis. J Clin Invest 92: 945-951.
46. Nahrendorf, M., et al. (2006) Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 114(14): 1504-1511.
47. Winter,P.M., et al. (2003) Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. Circulation 108(18): 2270-2274.
48. Tacke, F., et al. (2007) Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 117(1): 185-194.
49. Kooi, M.E., et al. (2003) Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 107(19): 2453-2458.
50. Durand, E., et al. (2007) Magnetic resonance imaging of ruptured plaques in the rabbit with ultrasmall superparamagnetic particles of iron oxide. J Vasc Res 44(2): 119-128
51. Von Zur Muhlen, C., et al. (2007) Superparamagnetic iron oxide binding and uptake as imaged by magnetic resonance is mediated by the integrin receptor Mac-1 (CD11b/CD18): implications on imaging of atherosclerotic plaques. Atherosclerosis 193(1): 102-111.
52. Rudd, J.H., et al. (2007) (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J Am Coll Cardiol 50(9): 892-86.
53. Tawakol, A., et al. (2005) Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol 12(3): 294-301.
54. Tawakol, A., et al. (2006) In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 48(9): 1818-1824.
55. Laurberg, J.M., et al. (2007) Imaging of vulnerable atherosclerotic plaques with FDGmicroPET: no FDG accumulation. Atherosclerosis 192(2): 275-282.
56. Chen, J., et al. (2002) In vivo imaging of proteolytic activity in atherosclerosis. Circulation 105(23): 2766-2771.
57. Jaffer, F.A., et al. (2007) Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor. Circulation 115(17): 2292-2298.
58. Heinecke, J.W. (2003) Oxidative stress: new approaches to diagnosis and prognosis in atherosclerosis. Am J Cardiol 91(3A): 12A-16A.
59. Seshiah, P.N., et al. (2002) Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res 91(5): 406-413.
60. Hazen, S.L. (2004) Myeloperoxidase and plaque vulnerability. Arterioscler Thromb Vasc Biol 24(7): 1143-1146.
61. Shepherd, J., et al. (2007) A fluorescent probe for the detection of myeloperoxidase activity in atherosclerosis-associated macrophages. Chem Biol 14(11): 1221-1231.
62. Tardif, J.C., et al. (2006) Vascular biomarkers and surrogates in cardiovascular disease. Circulation 113(25): 2936-2942.
63. Schaar, J.A., et al. (2003) Characterizing vulnerable plaque features with intravascular elastography. Circulation 108(21): 2636-2641.
64. Raggi, P., et al. (2005) Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES). Circulation 112(4): 563-571.
65. Ridker, P.M., et al. (2007) Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 297(6): 611-619.
66. Hochman, J.S., et al. (2006) Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med 355(23): 2395-2407.
67. Boden, W.E., et al. (2007) Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356(15): 1503-1516.